Alexey
Chupin
Research and Registration Director
Alexey Chupin graduated from the Ural State University of Economics with a degree in Economics.
In 2011, he was appointed CEO of JSC Binnopharm and later oversaw the company's integration with Alium.
In 2013, Alexey Chupin was appointed President of MEDSI before returning to JSC Binnopharm in 2014 and regaining his CEO position. Later on, he held the positions of Vice President for Business Development, Research and Registration and was a member of the Management Board at Alium. In 2019, he was appointed Research and Registration Director at Sintez.
Following the merger of Sistema’s pharmaceutical assets in 2020, Alexey Chupin was appointed Research and Registration Director at Binnopharm Group.
In 2011, he was appointed CEO of JSC Binnopharm and later oversaw the company's integration with Alium.
In 2013, Alexey Chupin was appointed President of MEDSI before returning to JSC Binnopharm in 2014 and regaining his CEO position. Later on, he held the positions of Vice President for Business Development, Research and Registration and was a member of the Management Board at Alium. In 2019, he was appointed Research and Registration Director at Sintez.
Following the merger of Sistema’s pharmaceutical assets in 2020, Alexey Chupin was appointed Research and Registration Director at Binnopharm Group.
Accolades
Order of Friendship for contributions to the production of a COVID-19 medicine.
